Principal Investigator
Dushyantha T. Jayaweera
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240414
Clinical Trial Summary
Phase 3 Double-blind Multicenter Randomized Active-Controlled
Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Biktarvy®(Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Virologically Suppressed People With HIV-1
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
HIV-related
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu